DK323688A - Pyridinforbindelser - Google Patents

Pyridinforbindelser

Info

Publication number: DK323688A
Authority: DK; Denmark
Prior art keywords: group; formula; lower alkyl; chem; hydrogen
Prior art date: 1987-06-15

Application number

DK323688A

Other languages

English (en)

Other versions

DK323688D0 (da

Inventor

Youichi Shiokawa

Atsushi Akahane

Hirohito Katayama

Takafumi Mitsunaga

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-15

Filing date

1988-06-14

Publication date

1988-12-16

1987-06-15 Priority claimed from GB878713908A external-priority patent/GB8713908D0/en

1987-08-20 Priority claimed from GB878719724A external-priority patent/GB8719724D0/en

1987-12-31 Priority claimed from GB878730330A external-priority patent/GB8730330D0/en

1988-06-14 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1988-06-14 Publication of DK323688D0 publication Critical patent/DK323688D0/da

1988-12-16 Publication of DK323688A publication Critical patent/DK323688A/da

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
-1 pyrazolopyridine compound Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Developing Agents For Electrophotography (AREA)
Position Input By Displaying (AREA)

DK323688A 1987-06-15 1988-06-14 Pyridinforbindelser DK323688A (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB878713908A GB8713908D0 (en)	1987-06-15	1987-06-15	Pyrazolopyridine compound
GB878719724A GB8719724D0 (en)	1987-08-20	1987-08-20	Pyrazolopyridine compound
GB878730330A GB8730330D0 (en)	1987-12-31	1987-12-31	Pyrazolopyridine compound & processes for preparation thereof

Publications (2)

Publication Number	Publication Date
DK323688D0 DK323688D0 (da)	1988-06-14
DK323688A true DK323688A (da)	1988-12-16

Family

ID=27263458

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK323688A DK323688A (da)	1987-06-15	1988-06-14	Pyridinforbindelser

Country Status (16)

Country	Link
US (6)	US4925849A (da)
EP (1)	EP0299209B1 (da)
JP (1)	JP2674099B2 (da)
KR (1)	KR890000483A (da)
CN (1)	CN1031376A (da)
AT (1)	ATE127801T1 (da)
AU (1)	AU615913B2 (da)
DE (1)	DE3854454T2 (da)
DK (1)	DK323688A (da)
ES (1)	ES2076935T3 (da)
FI (1)	FI882813A7 (da)
GR (1)	GR3017850T3 (da)
HU (1)	HU200180B (da)
IL (1)	IL86674A0 (da)
NO (1)	NO168585C (da)
PT (1)	PT87700B (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines
US5338743A (en) *	1988-06-06	1994-08-16	Fujisawa Pharmaceutical Co., Ltd.	New use of the adenosine antagonist
GB8901423D0 (en) *	1989-01-23	1989-03-15	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof
DE3942357A1 (de) *	1989-12-21	1991-06-27	Boehringer Mannheim Gmbh	3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
GB9015764D0 (en) *	1990-07-18	1990-09-05	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof
ATE211384T1 (de) *	1991-01-29	2002-01-15	Fujisawa Pharmaceutical Co	Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
GB9107513D0 (en) *	1991-04-10	1991-05-29	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof
AU672773B2 (en) *	1992-01-29	1996-10-17	E.I. Du Pont De Nemours And Company	Substituted phenylheterocyclic herbicides
US6358885B1 (en)	1992-01-29	2002-03-19	Mississippi State University	Substituted phenylheterocyclic herbicides
US5670455A (en) *	1992-01-29	1997-09-23	E. I. Du Pont De Nemours And Company	Substituted phenylheterocyclic herbicides
ATE161178T1 (de) *	1992-06-10	1998-01-15	Fujisawa Pharmaceutical Co	Pyrazolpyridine für die behandlung der anämie
JPH07507796A (ja) *	1992-06-17	1995-08-31	ファルマシア・アンド・アップジョン・カンパニー	抗−アテローム性動脈硬化剤および抗−高コレステロール血症剤として有用なピリジノ−，ピロリジノ−，およびアゼピノ−置換オキシム類
US5541213A (en) *	1993-06-24	1996-07-30	Eisai Co., Ltd.	Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
CN1046724C (zh) *	1993-12-29	1999-11-24	藤泽药品工业株式会社	吡唑并吡啶化合物、含有它们的药物组合物、及其制法与用途
US5646156A (en) *	1994-04-25	1997-07-08	Merck & Co., Inc.	Inhibition of eosinophil activation through A3 adenosine receptor antagonism
ATE220544T1 (de) *	1995-04-27	2002-08-15	Fujisawa Pharmaceutical Co	Neue verwendung von pyrazolopyridinverbindungen
DE69731948D1 (de) *	1996-04-25	2005-01-20	Fujisawa Pharmaceutical Co	Mittel zur vorbeugung und heilung ischämischer darmlesion und ileus
AUPO111096A0 (en) *	1996-07-18	1996-08-08	Fujisawa Pharmaceutical Co., Ltd.	New compound
EP0972525A4 (en) *	1997-03-18	2000-11-29	Fujisawa Pharmaceutical Co	PREVENTIVE AND HEALING AGENTS AGAINST HYPERPHOSPHATEMIA
ATE289295T1 (de) *	1997-04-22	2005-03-15	Euro Celtique Sa	Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker
EP1568690A1 (en) *	1997-04-22	2005-08-31	Euro-Celtique S.A.	The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
ATE281458T1 (de) *	1997-09-05	2004-11-15	Glaxo Group Ltd	Pharmazeutische zusammensetzung, enthaltend 2,3- diaryl-pyrazolo(1,5-b)pyridazin derivate
AUPP672198A0 (en) *	1998-10-23	1998-11-19	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
ATE275148T1 (de)	1998-11-03	2004-09-15	Glaxo Group Ltd	Pyrazolopyridin derivative als selektive cox-2 inhibitoren
WO2000052008A1 (en)	1999-02-27	2000-09-08	Glaxo Group Limited	Pyrazolopyridines
US20040152659A1 (en) *	1999-05-12	2004-08-05	Fujisawa Pharmaceutical Co. Ltd.	Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
FR2801308B1 (fr)	1999-11-19	2003-05-09	Oreal	COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES
GB9930358D0 (en)	1999-12-22	2000-02-09	Glaxo Group Ltd	Process for the preparation of chemical compounds
PE20020506A1 (es) *	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
AUPQ969800A0 (en) *	2000-08-28	2000-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
ES2245380T3 (es) *	2000-12-15	2006-01-01	Glaxo Group Limited	Pirazolopiridinas.
EP1377573B1 (en) *	2000-12-15	2005-07-27	Glaxo Group Limited	Pyrazolopyridine derivatives
TWI312347B (en)	2001-02-08	2009-07-21	Eisai R&D Man Co Ltd	Bicyclic nitrogen-containing condensed ring compounds
US7153855B2 (en) *	2001-03-08	2006-12-26	Smithkline Beecham Corporation	Pyrazolopyridinyl pyrimidine therapeutic compounds
EP1372643A1 (en) *	2001-03-30	2004-01-02	Smithkline Beecham Corporation	Pyrazolopyridines, process for their preparation and use as therapeutic compounds
WO2002078701A1 (en) *	2001-03-30	2002-10-10	Smithkline Beecham Corporation	Use of pyrazolopyridines as therapeutic compounds
JP4219171B2 (ja) *	2001-04-10	2009-02-04	スミスクラインビーチャムコーポレーション	抗ウイルス性ピラゾロピリジン化合物
US6756498B2 (en)	2001-04-27	2004-06-29	Smithkline Beecham Corporation	Process for the preparation of chemical compounds
AU2002305143A1 (en) *	2001-04-27	2002-11-11	Smithkline Beecham Corporation	Pyrazolo'1,5-a!pyridine derivatives
BR0209252A (pt) *	2001-04-27	2004-07-20	Eisai Co Ltd	Pirazolo[1,5-a]piridinas e medicamentos contendo as mesmas
AUPR548601A0 (en) *	2001-06-06	2001-06-28	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyrazinecompound and pharmaceutical use thereof
KR20040018281A (ko) *	2001-06-21	2004-03-02	스미스클라인 비참 코포레이션	포진 바이러스 감염의 예방 및 치료를 위한 이미다조[1，２－α]피리딘 유도체
ES2286272T3 (es) *	2001-09-07	2007-12-01	Smithkline Beecham Corporation	Pirizolo-piridinas para el tratamiento de infecciones por herpes.
US7244740B2 (en) *	2001-10-05	2007-07-17	Smithkline Beecham Corporation	Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
WO2003050120A1 (en) *	2001-12-11	2003-06-19	Smithkline Beecham Corporation	Pyrazolo-pyridine derivatives as antiherpes agents
US20040021778A1 (en) *	2002-08-05	2004-02-05	Oldani Jerome L.	Security system with remote access and control
WO2004033454A1 (en) *	2002-10-03	2004-04-22	Smithkline Beecham Corporation	Therapeutic compounds based on pyrazolopyridine derivatives
US7176216B2 (en) *	2002-10-22	2007-02-13	Eisai Co., Ltd.	7-phenylpyrazolopyridine compounds
AU2003275589B2 (en) *	2002-10-22	2009-05-28	Eisai R & D Management Co., Ltd.	7-phenyl pyrazolopyridine compounds
TW200517114A (en)	2003-10-15	2005-06-01	Combinatorx Inc	Methods and reagents for the treatment of immunoinflammatory disorders
JP2007512337A (ja)	2003-11-21	2007-05-17	コンビナトアールエックスインコーポレーティッド	炎症性障害の治療のための方法および試薬
US8067433B2 (en)	2005-11-09	2011-11-29	Zalicus Inc.	Methods, compositions, and kits for the treatment of ophthalmic disorders
JP5352452B2 (ja) *	2006-06-06	2013-11-27	メディシノバ，インコーポレイテッド	置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法
EP1939180A1 (en) *	2006-12-20	2008-07-02	sanofi-aventis	Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
US7536799B2 (en) *	2007-06-07	2009-05-26	Keson Industries	Chalk line apparatus with strategically located chalk fill opening
MY152687A (en) *	2008-04-15	2014-10-31	Eisai R&D Man Co Ltd	3-phenylpyrazolo[5,1-b]thiazole compound
US20100092479A1 (en) *	2008-08-18	2010-04-15	Combinatorx (Singapore) Pte. Ltd.	Compositions and methods for treatment of viral diseases
EP2177218A1 (en)	2008-10-15	2010-04-21	Medizinische Universität Wien	Regenerative therapy
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
JPWO2011043387A1 (ja) *	2009-10-08	2013-03-04	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラゾロオキサゾール化合物
KR20150003766A (ko)	2012-04-26	2015-01-09	브리스톨-마이어스 스큅 컴퍼니	혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 및 이미다조피리다진 유도체
SG11201406759YA (en)	2012-04-26	2014-11-27	Bristol Myers Squibb Co	Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
ES2640916T3 (es)	2012-04-26	2017-11-07	Bristol-Myers Squibb Company	Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor 4 activados por proteasa (PAR4) para tratar agregación plaquetaria
US9617279B1 (en)	2014-06-24	2017-04-11	Bristol-Myers Squibb Company	Imidazooxadiazole compounds
US9598419B1 (en)	2014-06-24	2017-03-21	Universite De Montreal	Imidazotriazine and imidazodiazine compounds
SG11202112828SA (en) *	2019-06-04	2021-12-30	Hager Biosciences Llc	Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists
US11970499B1 (en)	2023-12-22	2024-04-30	King Faisal University	Pyrazolo[1,5-c]pyrimidine compounds as CK2 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5229318B2 (da) *	1972-03-30	1977-08-01
US4017597A (en) *	1974-10-30	1977-04-12	Monsanto Company	Unitized solid phase immunoassay kit and method
US4097483A (en) *	1974-11-01	1978-06-27	Kyorin Pharmaceutical Co., Ltd.	Pyrazolo 1,5-a!pyridines
JPS5154583A (en) *	1974-11-01	1976-05-13	Kyorin Seiyaku Kk	Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
AU556031B2 (en) *	1982-06-16	1986-10-16	May And Baker Ltd.	3-(n,n-dimethylcarbamoyl)pyrazolo(1,5-alpha)-pyridine
JPS60248689A (ja) *	1984-05-24	1985-12-09	Mitsubishi Paper Mills Ltd	３−（３′−ピラゾロ〔１，５−ａ〕ピリジル）アクロレイン誘導体
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines

1988
- 1988-06-06 US US07/202,526 patent/US4925849A/en not_active Expired - Fee Related
- 1988-06-09 PT PT87700A patent/PT87700B/pt not_active IP Right Cessation
- 1988-06-09 IL IL86674A patent/IL86674A0/xx unknown
- 1988-06-10 AU AU17602/88A patent/AU615913B2/en not_active Ceased
- 1988-06-11 ES ES88109331T patent/ES2076935T3/es not_active Expired - Lifetime
- 1988-06-11 AT AT88109331T patent/ATE127801T1/de not_active IP Right Cessation
- 1988-06-11 EP EP88109331A patent/EP0299209B1/en not_active Expired - Lifetime
- 1988-06-11 DE DE3854454T patent/DE3854454T2/de not_active Expired - Fee Related
- 1988-06-13 FI FI882813A patent/FI882813A7/fi not_active Application Discontinuation
- 1988-06-14 HU HU883046A patent/HU200180B/hu not_active IP Right Cessation
- 1988-06-14 KR KR1019880007185A patent/KR890000483A/ko not_active Ceased
- 1988-06-14 NO NO882608A patent/NO168585C/no unknown
- 1988-06-14 CN CN88104322A patent/CN1031376A/zh active Pending
- 1988-06-14 JP JP63146080A patent/JP2674099B2/ja not_active Expired - Lifetime
- 1988-06-14 DK DK323688A patent/DK323688A/da not_active Application Discontinuation
1989
- 1989-09-15 US US07/407,747 patent/US4994453A/en not_active Expired - Fee Related
1990
- 1990-03-12 US US07/492,486 patent/US5087629A/en not_active Expired - Fee Related
- 1990-03-19 US US07/495,799 patent/US5102878A/en not_active Expired - Fee Related
- 1990-06-19 US US07/540,325 patent/US5102869A/en not_active Expired - Fee Related
1992
- 1992-10-30 US US07/968,664 patent/US5296490A/en not_active Expired - Fee Related
1995
- 1995-10-25 GR GR950402954T patent/GR3017850T3/el unknown

Also Published As

Publication number	Publication date
US5102878A (en)	1992-04-07
EP0299209A2 (en)	1989-01-18
US4925849A (en)	1990-05-15
PT87700A (pt)	1988-07-01
US5087629A (en)	1992-02-11
NO168585C (no)	1992-03-11
CN1031376A (zh)	1989-03-01
EP0299209A3 (en)	1990-05-09
ATE127801T1 (de)	1995-09-15
NO168585B (no)	1991-12-02
PT87700B (pt)	1992-10-30
US5102869A (en)	1992-04-07
NO882608L (no)	1988-12-16
DE3854454T2 (de)	1996-02-15
JP2674099B2 (ja)	1997-11-05
JPS6445385A (en)	1989-02-17
US4994453A (en)	1991-02-19
FI882813A0 (fi)	1988-06-13
IL86674A0 (en)	1988-11-30
AU615913B2 (en)	1991-10-17
US5296490A (en)	1994-03-22
DE3854454D1 (de)	1995-10-19
AU1760288A (en)	1988-12-15
HUT47110A (en)	1989-01-30
KR890000483A (ko)	1989-03-14
FI882813A7 (fi)	1988-12-16
NO882608D0 (no)	1988-06-14
ES2076935T3 (es)	1995-11-16
EP0299209B1 (en)	1995-09-13
DK323688D0 (da)	1988-06-14
HU200180B (en)	1990-04-28
GR3017850T3 (en)	1996-01-31

Legal Events

Date	Code	Title	Description
1995-02-27	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK323688D0 (da)	1988-06-14	Pyridinforbindelser
DK0467248T3 (da)	1999-07-05	Pyrazolopyridinforbindelse og fremgangsmåder til fremstilling heraf
IL93050A0 (en)	1990-11-05	Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO903438L (no)	1991-02-08	Fremgangsmaate for fremstilling av tiazolderivater.
MY112232A (en)	2001-05-31	Indole derivatives
DK162519C (da)	1992-03-30	Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende forbindelserne
DK0513675T3 (da)	1996-09-30	Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
GB8401093D0 (en)	1984-02-15	Cephem compounds
ES2092470T3 (es)	1996-12-01	Derivados de pirrolidina.
FI893570A0 (fi)	1989-07-26	Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi